Used properly, healthcare data can save lives and improve quality of life. Unfortunately, the current process of accessing health data can be challenging because many participants are reluctant to submit. It is also expensive for smaller organizations. As a result, providing life-changing medicine is only possible for larger organizations, although it takes a long time to gather the necessary data.
On the other hand, medical associations must be careful when using data. Many patients are afraid to divulge their health information so that it is not shared outside of their doctor and hospital. Some patients have admitted to concealing information from their providers for safety concerns. If this happens, there is a risk that medical organizations will lose data that can help them develop new treatments for the critically ill, which further hinders the development of medicine.
Aimedis, an e-health care provider, is working to address these concerns by launching the world’s first medical and scientific non-fungible token (NFT). The introduction of a standardized process will allow professional users to provide anonymized health care data in a blockchain. Institutions, researchers and related companies can then pay for access to this data for research purposes.
Patient data protection
In practice, patients can voluntarily share their data from anywhere through accredited healthcare providers such as the NFT. Due to the decentralized nature of the blockchain, patients are more likely to share their data anonymously because they know they are secured by strong encryption.
In exchange for their anonymized data, patients will receive an Aimedis token (AIMX) and may also be eligible for discounts on other services provided by the eHealth platform. Participants are also rewarded through an ecosystem that includes various forms of content and other benefits for members only.
Thanks to greater security, companies gain access to a larger database, which they can then use to treat other people who have similar health problems with drugs, treatments or vaccines, which effectively democratizes research.
Companies that need this data have easy further access to it, and their work can improve their products. All revenues generated can now be predicted and determined under this new standard for medical data. Companies that would not otherwise have access to this data can therefore partner with other organizations and purchase the necessary data.
In order to implement this model and other eHealth functions, Aimedis uses a multi-blockchain system that implements a decentralized, non-public blockchain for storing transaction IDs, vaccinations and organ donor cards. Tokens are processed in a public blockchain, while NFTs exist in either a public or non-public chain, depending on the level of encryption.
Each of the unique NFTs will create data organized into carefully sorted sets so that it can be easily tracked in the blockchain. The use of blockchain technology will also ensure that a transparent record of all transactions is maintained.
This could completely change the approach to medicine and greatly accelerate progress in creating new drugs.